ClinicalTrials.Veeva

Menu

ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures

J

Johann Wolfgang Goethe University Hospital

Status

Suspended

Conditions

Peripheral Arterial Occlusive Disease

Study type

Observational

Funder types

Other

Identifiers

NCT00593762
E 19/05

Details and patient eligibility

About

The purpose of the study is to determine the response to aspirin (ASA) and Clopidogrel in patients with peripheral arterial occlusive disease (PAOD) requiring interventional procedures and to investigate if patients with "resistance" to ASA or Clopidogrel have an unfavourable outcome during long-term follow-up

Enrollment

200 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • PAOD patients
  • Age 18-85 years
  • Need for a catheter interventional procedure
  • Antithrombotic therapy with aspirin or clopidogrel

Exclusion criteria

  • Comedication additionally compromising platelet function
  • Known bleeding disorder
  • Life expectancy < 6 months

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems